Foghorn Therapeutics Inc. discloses a restructuring plan in an SEC filing

Industry: Biotech
Filed with the SEC: October 1, 2026
Share of workforce: 40%
Whose workers: Scope not stated
In the report for: October 1, 2026

What happened

Foghorn Therapeutics Inc. disclosed a restructuring plan in an SEC filing without stating how many jobs it affects. The filing puts the reduction at about 40% of its workforce.

Sources

SEC EDGAR · SEC filing · Oct 1, 2026
In connection with this decision, the Company announced a reduction in its workforce by approximately 40% of its current workforce.
Read the source

This reports what the source says. It says nothing about any individual's immigration status.